These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 37374999)
21. Diversity, frequency and antifungal resistance of Candida species in patients with type 2 diabetes mellitus. Aitken-Saavedra J; Lund RG; González J; Huenchunao R; Perez-Vallespir I; Morales-Bozo I; Urzúa B; Tarquinio SC; Maturana-Ramírez A; Martos J; Fernandez-Ramires R; Molina-Berríos A Acta Odontol Scand; 2018 Nov; 76(8):580-586. PubMed ID: 30045641 [TBL] [Abstract][Full Text] [Related]
22. Perianal candidosis--a comparative study with mupirocin and nystatin. de Wet PM; Rode H; van Dyk A; Millar AJ Int J Dermatol; 1999 Aug; 38(8):618-22. PubMed ID: 10487455 [TBL] [Abstract][Full Text] [Related]
23. Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans. Melkoumov A; Goupil M; Louhichi F; Raymond M; de Repentigny L; Leclair G J Antimicrob Chemother; 2013 Sep; 68(9):2099-105. PubMed ID: 23620465 [TBL] [Abstract][Full Text] [Related]
24. Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study. de Castro RD; de Souza TM; Bezerra LM; Ferreira GL; Costa EM; Cavalcanti AL BMC Complement Altern Med; 2015 Nov; 15():417. PubMed ID: 26601661 [TBL] [Abstract][Full Text] [Related]
25. [Susceptibility to nystatin of oral Candida isolates and its correlation with the response to treatment]. Santa Anna LM; Díaz Suárez LA; Illnait Zaragozí MT; Perurena Lancha MR; Cantelar de Francisco N; Fernández Andreu CM; Martínez Machín G Rev Cubana Med Trop; 2010; 62(3):237-44. PubMed ID: 23437555 [TBL] [Abstract][Full Text] [Related]
26. Effect of an antifungal denture liner on the saliva yeast count in patients with denture stomatitis: a pilot study. Geerts GA; Stuhlinger ME; Basson NJ J Oral Rehabil; 2008 Sep; 35(9):664-9. PubMed ID: 18793352 [TBL] [Abstract][Full Text] [Related]
27. Supragingival microbiome variations and the influence of Yang H; Ma Y; Gao H; Xie X; Wang H; Li X; Bai Y J Oral Microbiol; 2024; 16(1):2366056. PubMed ID: 38882240 [TBL] [Abstract][Full Text] [Related]
28. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents. Choukri F; Benderdouche M; Sednaoui P J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913 [TBL] [Abstract][Full Text] [Related]
29. Effects of Streptococcus salivarius K12 with nystatin on oral candidiasis-RCT. Hu L; Mao Q; Zhou P; Lv X; Hua H; Yan Z Oral Dis; 2019 Sep; 25(6):1573-1580. PubMed ID: 31177581 [TBL] [Abstract][Full Text] [Related]
30. The impact of various time intervals on the supragingival plaque dynamic core microbiome. Jiang WX; Hu YJ; Gao L; He ZY; Zhu CL; Ma R; Huang ZW PLoS One; 2015; 10(5):e0124631. PubMed ID: 25942317 [TBL] [Abstract][Full Text] [Related]
31. The microbiological profiles of saliva, supragingival and subgingival plaque and dental caries in adults with and without type 2 diabetes mellitus. Hintao J; Teanpaisan R; Chongsuvivatwong V; Ratarasan C; Dahlen G Oral Microbiol Immunol; 2007 Jun; 22(3):175-81. PubMed ID: 17488443 [TBL] [Abstract][Full Text] [Related]
32. A randomized controlled trial to evaluate the effectiveness of a novel mouth rinse in patients with gingivitis. Newman BA; Rosebrough CN; Tamashiro RA; Dias Ribeiro AP; Whitlock JA; Sidhu G; Aukhil I; Porral DY; Progulske-Fox A; Myntti MF; Wang GP BMC Oral Health; 2022 Nov; 22(1):461. PubMed ID: 36324127 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of different formulations of nystatin in an experimental model of oral candidiasis in sialoadenectomized rats. Pérez-Sayáns M; Beiro-Fuentes R; Otero-Rey EM; Chamorro-Petronacci CM; Gándara-Vila P; Somoza-Martín JM; García-García A; Blanco-Carrión A J Dent Sci; 2021 Jan; 16(1):123-130. PubMed ID: 33384788 [TBL] [Abstract][Full Text] [Related]
34. Plaque bacterial microbiome diversity in children younger than 30 months with or without caries prior to eruption of second primary molars. Xu H; Hao W; Zhou Q; Wang W; Xia Z; Liu C; Chen X; Qin M; Chen F PLoS One; 2014; 9(2):e89269. PubMed ID: 24586647 [TBL] [Abstract][Full Text] [Related]
35. Preliminary characterization of the oral microbiota of Chinese adults with and without gingivitis. Huang S; Yang F; Zeng X; Chen J; Li R; Wen T; Li C; Wei W; Liu J; Chen L; Davis C; Xu J BMC Oral Health; 2011 Dec; 11():33. PubMed ID: 22152152 [TBL] [Abstract][Full Text] [Related]
36. A randomized, double-blind clinical study to assess the antimicrobial effects of a cetylpyridinium chloride mouth rinse on dental plaque bacteria. Hu D; Li X; Sreenivasan PK; DeVizio W Clin Ther; 2009 Nov; 31(11):2540-8. PubMed ID: 20109998 [TBL] [Abstract][Full Text] [Related]
37. Distinctions and associations between the microbiota of saliva and supragingival plaque of permanent and deciduous teeth. Shi W; Tian J; Xu H; Zhou Q; Qin M PLoS One; 2018; 13(7):e0200337. PubMed ID: 29979786 [TBL] [Abstract][Full Text] [Related]
38. Oral candidiasis: effects of antifungal therapy upon clinical signs and symptoms, salivary antibody, and mucosal adherence of Candida albicans. Epstein JB; Pearsall NN; Truelove EL Oral Surg Oral Med Oral Pathol; 1981 Jan; 51(1):32-6. PubMed ID: 7007953 [TBL] [Abstract][Full Text] [Related]
39. The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion. Ellepola AN; Samaranayake LP Oral Dis; 1998 Dec; 4(4):260-7. PubMed ID: 10200705 [TBL] [Abstract][Full Text] [Related]